Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows
Key takeaways
- Healthcare Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows By Bruce Japsen,
- Forbes contributors publish independent expert analyses and insights.
- Financial terms of the acquisition weren’t disclosed.
Healthcare Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows By Bruce Japsen,
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy.Follow Author Jul 02, 2026, 09:20am EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.Summary Peak Rock Capital has acquired Asembia, a fast-growing provider of specialty pharmacy services, including distribution, group purchasing, and technology connecting patients. Founded in 2004, Asembia addresses the specialized needs of medicines that now comprise over 60% of employer drug spending, particularly with the rise of GLP-1s. Asembia CEO Lawrence Irene stated Peak Rock's investment will fuel growth, technology, and innovation, improving experiences for patients, prescribers, and partners. The company has evolved to offer crucial technology solutions, exemplified by its ASPN digital retail network. This platform streamlines patient access to therapies by connecting drug makers, prescribers, and pharmacies, effectively reducing barriers like financial hurdles and prior authorizations.
The private equity firm Peak Rock Capital is buying Asembia, a fast-growing provider of services surrounding specialty pharmacy including distribution, group purchasing and technology connecting pharmacies, drug makers, patients and other stakeholders.gettyPeak Rock Capital has purchased Asembia, a fast-growing provider of services surrounding specialty pharmacy including distribution, group purchasing and technology connecting patients, the companies announced Thursday.